Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PARK, John W")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 42

  • Page / 2
Export

Selection :

  • and

Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast CancerTRAINA, Tiffany A; RUGO, Hope S; SEIDMAN, Andrew D et al.Journal of clinical oncology. 2010, Vol 28, Num 4, pp 628-633, issn 0732-183X, 6 p.Article

Targeted Tumor Cell Internalization and Imaging of Multifunctional Quantum Dot-Conjugated Immunoliposomes in Vitro and in VivoWENG, Kevin C; NOBLE, Charles O; PAPAHADJOPOULOS-STERNBERG, Brigitte et al.Nano letters (Print). 2008, Vol 8, Num 9, pp 2851-2857, issn 1530-6984, 7 p.Article

Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinomaRINI, Brian I; WEINBERG, Vivian; SHAW, Vanessa et al.Cancer. 2004, Vol 101, Num 1, pp 90-95, issn 0008-543X, 6 p.Article

Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cellsMAMOT, Christoph; DRUMMOND, Daryl C; GREISER, Udo et al.Cancer research (Baltimore). 2003, Vol 63, Num 12, pp 3154-3161, issn 0008-5472, 8 p.Article

Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal CarcinomatosisMAGBANUA, Mark Jesus M; MELISKO, Michelle; PARK, John W et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 23, pp 7134-7143, issn 0008-5472, 10 p.Article

Biologic markers determine both the risk and the timing of recurrence in breast cancerESSERMAN, Laura J; MOORE, Dan H; KREPS, Stig et al.Breast cancer research and treatment. 2011, Vol 129, Num 2, pp 607-616, issn 0167-6806, 10 p.Article

A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neuPEETHAMBARAM, Prema P; MELISKO, Michelle E; RINN, Kristine J et al.Clinical cancer research (Print). 2009, Vol 15, Num 18, pp 5937-5944, issn 1078-0432, 8 p.Article

Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purificationNELLIS, David F; EKSTROM, Denise L; KEELUNG HONG et al.Biotechnology progress. 2005, Vol 21, Num 1, pp 205-220, issn 8756-7938, 16 p.Article

Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agentsKRAUZE, Michal T; SAITO, Ryuta; NOBLE, Charles et al.Journal of neurosurgery. 2005, Vol 103, Num 5, pp 923-929, issn 0022-3085, 7 p.Article

Convection-enhanced delivery of targeted quantum dot―immunoliposome hybrid nanoparticles to intracranial brain tumor modelsWENG, Kevin C; HASHIZUME, Rintaro; PARK, John W et al.Nanomedicine (London. Print). 2013, Vol 8, Num 12, pp 1913-1925, issn 1743-5889, 13 p.Article

Development of a highly stable and targetable nanoliposomal formulation of topotecanDRUMMOND, Daryl C; NOBLE, Charles O; BENZ, Christopher C et al.Journal of controlled release. 2010, Vol 141, Num 1, pp 13-21, issn 0168-3659, 9 p.Article

Treatment with autologous antigen-presenting cells activated with the HER-2 -based antigen lapuleucel-t : Results of a phase I study in immunologic and clinical activity in HER-2-overexpressing breast cancerPARK, John W; MELISKO, Michelle E; ESSERMAN, Laura J et al.Journal of clinical oncology. 2007, Vol 25, Num 24, pp 3680-3687, issn 0732-183X, 8 p.Article

EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cellsMAMOT, Christoph; RITSCHARD, Reto; KÜNG, Willy et al.Journal of drug targeting. 2006, Vol 14, Num 4, pp 215-223, issn 1061-186X, 9 p.Article

Brain metastases of breast cancerMELISKO, Michelle E; KUNWAR, Sandeep; PRADOS, Michael et al.Expert review of anticancer therapy. 2005, Vol 5, Num 2, pp 253-268, issn 1473-7140, 16 p.Article

Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: An updateKELLOFF, Gary J; BAST, Robert C; WOUDE, George F et al.Clinical cancer research. 2004, Vol 10, Num 11, pp 3881-3884, issn 1078-0432, 4 p.Article

Phase I Dose-Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy in Patients With Human Epidermal Growth Factor Receptor 2―Overexpressing Breast CancerCHIEN, A. Jo; MUNSTER, Pamela N; MOASSER, Mark M et al.Journal of clinical oncology. 2014, Vol 32, Num 14, pp 1472-1479, issn 0732-183X, 8 p.Article

Genomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer PatientsMAGBANUA, Mark Jesus M; SOSA, Eduardo V; ROY, Ritu et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 1, pp 30-40, issn 0008-5472, 11 p.Article

A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast CancerDICKLER, Maura N; RUGO, Hope S; GILEWSKI, Teresa A et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7878-7883, issn 1078-0432, 6 p.Article

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategyDRUMMOND, Daryl C; NOBLE, Charles O; ZEXIONG GUO et al.Cancer research (Baltimore). 2006, Vol 66, Num 6, pp 3271-3277, issn 0008-5472, 7 p.Article

Real-time imaging and quantification of brain delivery of liposomesKRAUZE, Michal T; FORSAYETH, John; PARK, John W et al.Pharmaceutical research. 2006, Vol 23, Num 11, pp 2493-2504, issn 0724-8741, 12 p.Article

Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysisNELLIS, David F; GIARDINA, Steven L; PERKINS, Shelley C et al.Biotechnology progress. 2005, Vol 21, Num 1, pp 221-232, issn 8756-7938, 12 p.Article

Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors : Results from a phase I studyLIU, Glenn; RUGO, Hope S; CHARNSANGAVEJ, Chusilp et al.Journal of clinical oncology. 2005, Vol 23, Num 24, pp 5464-5473, issn 0732-183X, 10 p.Conference Paper

Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imagingDICKINSON, Peter J; LECOUTEUR, Richard A; KIRPOTIN, Dmitri B et al.Journal of neurosurgery. 2008, Vol 108, Num 5, pp 989-998, issn 0022-3085, 10 p.Article

Pharmacokinetics and In Vivo Drug Release Rates in Liposomal Nanocarrier DevelopmentDRUMMOND, Daryl C; NOBLE, Charles O; HAYES, Mark E et al.Journal of pharmaceutical sciences. 2008, Vol 97, Num 11, pp 4696-4740, issn 0022-3549, 45 p.Article

Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors : Pharmacology and efficacyNOBLE, Charles O; KRAUZE, Michal T; DRUMMOND, Daryl C et al.Cancer research (Baltimore). 2006, Vol 66, Num 5, pp 2801-2806, issn 0008-5472, 6 p.Article

  • Page / 2